Protagenic Therapeutics Inc new increased III. Quarter net loss per share of $-0.05 compare to net loss per share of $-0.05 recorded in the same quarter a year ago a decrease compare to $-0.04 realized in previous quarter.
III. Quarter
Earnings Per Share
Revenues
$ -0.05
$
0 Mill
Unch.
Unch.
Protagenic Therapeutics Inc New's Revenue
fell by
0 % in III. Quarter (Sep 30 2022) year on year,
to $0 million and
declined by
sequentially.
Protagenic Therapeutics Inc New is Expected to report next financial results on April 06, 2023.
Protagenic Therapeutics Inc New's
in III. Quarter recorded net loss of $-0.925 million, an increase from net loss of $-0.878 million in III. Quarter a year ago.
